Abstract:Osteogenic protein-1 (OP-l) or bone morphogenetic protein-7 (BMP-7) stimulates cartilage formation in mouse bone rudiments irt vitro but arrests terminal differentiation of prehypertrophic chondrocytes into hypertrophic chondrocytes. In this study we report that these effects of OP-l depend on the developmental stage of the bone rudiment, early stages (E14 and E15 metatarsals) being most responsive. E17 metatarsals that already contained a hypertrophic area that had initiated mineralization were no longer affected by OP-1. We then investigated whether the sensitivity of the early long bone rudiments to OP-l correlated with high expression of the OP-l binding type I serine/threonine kinase receptors (activin receptor-like kinase: ALK-2/ActR-I, ALK-3/BMPR-IA or ALK-6/BMPR-IB) at this early stage. We did not find ang significant difference in overall mRNA levels of these ALKs between stages E14 through E17 as assessed by RNase protection assays. However, by immunohistochemistry we found that ALK-6 staining was strong in E14 early cartilage primordium and its future perichondrium but dropped sharply to low levels in these cell types until onset of chondrocyte (pre)hypertrophy at E16, By contrast, ALK-2 and ALK-3 immunostainings in E14 were barely detectable. We also examined by immunohistochemistry the local synthesis of OP-1. OP-l was present in E14 early chondrocytes and forming perichondrium but in low amounts; however, production of OP-l increased in these cell types with age. Ali three receptor types as well as OP-l were present in significant amounts in prehypertrophic chondrocytes and late hypertrophic chondrocytes including those undergoing mineralization, The temporary high immunostaining for ALK-6 in the early proliferating chondrocytes and future perichondrium of E14 bone rudiments, and its absence in older bones correlated with the sensitivity of chondrocytes and perichondrium to (exogenous) OP-1, We therefore propose that the effects of OP-l on these cells in vitro are mediated by ALK-6/BMPR-IB. We furthermore conclude that locally produced OP-l is a potential autocrine/paracrine growth factor, Increased local production of OP-l may be partially responsible for the age-related decrease in responsiveness to exogenous OP-l with respect to hypertrophy and mineralization of cartilage.

Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.

Functional Antagonism Between Activin And Osteogenic Protein-1 In Human Embryonal Carcinoma Cells

Identification of Type I Receptors for Osteogenic Protein-1 and Bone Morphogenetic Protein-4.

Intracellular signaling of osteogenic protein-1 through Smad5 activation.

Osteopontin in Bone Metabolism and Bone Diseases

Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors

Engagement of Activin and Bone Morphogenetic Protein Signaling Pathway Smad Proteins in the Induction of Inhibin B Production in Ovarian Granulosa Cells.

Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis

Bone Morphogenetic Protein Receptors and Activin Receptors Are Highly Expressed in Ossified Ligament Tissues of Patients with Ossification of the Posterior Longitudinal Ligament.

Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities

Differential effects of osteogenic protein-1 (BMP-7) on gene expression of BMP and GDF family members during differentiation of the mouse MC615 chondrocyte cells

Transforming growth factor-beta1 supports the rapid morphogenesis of heterotopic endochondral bone initiated by human osteogenic protein-1 via the synergistic upregulation of molecular markers

The Optimal Dose of Recombinant Human Osteogenic Protein-1 Enhances Differentiation of Mouse Osteoblast-Like Cells: an in Vitro Study

Cartilage-derived morphogenetic proteins and osteogenic protein-1 differentially regulate osteogenesis.

Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects.

Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis

How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva

Expression Of Transforming Growth Factor-Beta 1, Activin A, And Their Receptors In Thyroid Follicle Cells: Negative Regulation Of Thyrocyte Growth And Function

Correlation between ALK-6 (BMPR-IB) distribution and responsiveness to osteogenic protein-1 (BMP-7) in embryonic mouse bone rudiments.